Skip to main content

Blog

REGENXBIO Initiates Pivotal Phase of AFFINITY DUCHENNE® Trial of RGX-202 Gene Therapy, Reports Positive Functional Data

...

Calling All Adults with Duchenne & Becker: Join the 2025 PPMD Adult Advisory Committee

...

REGENXBIO Shares Updates on Phase I/II AFFINITY DUCHENNE® trial of RGX-202

...

Solid Biosciences Shares Updates on INSPIRE DUCHENNE Clinical Trial of SGT-003

...

Sarepta Announces Discontinuation of SRP-5051 Development for Duchenne

...

WATCH: Exploring Muscle Regeneration – A New Approach with Satellos (Webinar Recording)

...

FDA Accepts Translarna NDA Resubmission for Review

...

Flu Season Ready: Protecting Yourself and Your Family

...

Catch Up on World Muscle Society 2024

...

WATCH: SHIELD DMD – A Bone Health Study in Duchenne (Webinar Recording)

...